BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19057029)

  • 1. Clinical outcome of patients with diabetes mellitus and chronic total occlusion treated with drug-eluting stents.
    De Felice F; Fiorilli R; Parma A; Nazzaro MS; Dibra A; Musto C; De Santis A; Violini R
    J Invasive Cardiol; 2008 Dec; 20(12):651-4. PubMed ID: 19057029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
    Han YL; Zhang J; Li Y; Wang SL; Jing QM; Yi XH; Ma YY; Luan B; Wang G; Wang B
    Chin Med J (Engl); 2009 Mar; 122(6):643-7. PubMed ID: 19323927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions.
    Zhang J; Han YL; Li Y; Wang SL; Jing QM; Wang XZ; Ma YY; Luan B; Wang G; Wang B
    Chin Med J (Engl); 2010 Apr; 123(7):789-93. PubMed ID: 20497665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
    De Felice F; Fiorilli R; Parma A; Nazzaro M; Musto C; Sbraga F; Caferri G; Violini R
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1260-5. PubMed ID: 20129553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
    Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
    Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
    De Felice F; Fiorilli R; Parma A; Menichelli M; Nazzaro MS; Pucci E; Dibra A; Musto C; Violini R
    Int J Cardiol; 2009 Mar; 132(3):337-41. PubMed ID: 18234373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
    Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM
    J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
    Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
    Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
    Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease.
    Briguori C; Colombo A; Airoldi F; Focaccio A; Iakovou I; Chieffo A; Michev I; Montorfano M; Bonizzoni E; Ricciardelli B; Condorelli G
    Am Heart J; 2005 Oct; 150(4):807-13. PubMed ID: 16209986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Abbott JD; Voss MR; Nakamura M; Cohen HA; Selzer F; Kip KE; Vlachos HA; Wilensky RL; Williams DO
    J Am Coll Cardiol; 2007 Nov; 50(21):2029-36. PubMed ID: 18021868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
    Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
    Harjai KJ; Orshaw P; Shenoy C; Acharji S; Sporn D; Aboufares A; Stapleton D
    J Interv Cardiol; 2008 Aug; 21(4):315-24. PubMed ID: 18754967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.